Fundz

Who to call at BIO-PATH HOLDINGS, INC., and when

Fundz watches for the moments BIO-PATH HOLDINGS, INC. starts buying, and tells you who to reach.

  • An alert the day BIO-PATH HOLDINGS, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BIO-PATH HOLDINGS, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BIO-PATH HOLDINGS, INC.. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KHIGH RiskNeutral

BIO-PATH HOLDINGS, INC.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

www.biopathholdings.com
Filed: Oct 22, 2025BELLAIRE, TexasCIK: 0001133818Biotechnology
Full company profileView on SEC.gov

2 executive changes at Bio-Path Holdings in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.

See every company with multiple executive changes →

AI Executive Summary

AI-powered analysis of 8-K filing content

On October 22, 2025, Bio-Path Holdings appointed Vikram Grover as President, Chief Executive Officer, Chief Financial Officer, and director, replacing Douglas Morris as Interim CEO and Interim CFO; Morris remains on the Board, and director Paul Aubert also resigned. The change consolidates the top two executive roles under one new leader and marks a significant shift in management and board composition.

Key Takeaways

Vikram Grover was appointed President, CEO, CFO, and a member of the Board on October 22, 2025, consolidating the top executive and finance roles under one person.

Douglas Morris resigned as Interim CEO and Interim CFO but continues to serve as a Board member, preserving some continuity at the board level.

2 more takeaways

Related Filings (6)

6 more filings from BIO-PATH HOLDINGS, INC. in the last 90 days

Filing Overview

Form Type8-K
Filing DateOct 22, 2025
Item5.02
CategoryExecutive Change
CIK0001133818
Accession #0001133818
Risk LevelHIGH
SentimentNeutral
Signalinformational
Topics
executive hireexecutive departureboard change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

BIO-PATH HOLDINGS, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.